Study suggests new molecular strategy for treating fragile X syndrome February 20, 2025 … drug, but he noted that there are some drugs in clinical development that specifically target the 2B subunit of NMDA …
IGF1 … is that the effects of MeCP2 are mediated in postnatal development through microRNAs that regulate IGF1 signaling. …
